The FRAMIG 2000 - II survey. Therapeutical data;Comportements thérapeutiques des migraineux. FRAMIG 2000-II

Douleurs

Volumn 2, Issue 5, 2001, Pages 240-243

  Lucas, C ^a   Lanteri Minet, M ^a   Chaffaut, C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

MIDAS; Migraine; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ERGOT ALKALOID; METOCLOPRAMIDE; OPIATE; PARACETAMOL;

CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DRUG CHOICE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; REVIEW; TREATMENT PLANNING;

EID: 0035204106     PISSN: 16245687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. FRAMIG 99-I. Caractéristiques des patients migraineux
2. La migraine en France: Étude épidémiologique, impact socio-économique et qualité de vie
3. FRAMIG 99-III. Comportements thérapeutiques des migraineux
4. An international study to assess the reliability of the Migraine Disability Assessment (MIDAS) score
5. The clinical utility of the Migraine Disability Assessment (MIDAS) questionnaire
6. Commitee on clinical trials in migraine. Guidelines for controlled trials of drugs in migraine
7. Transformation of episodic migraine into daily headache: Analysis of factors
8. Clinical features of chronic daily headache
9. Les nouveaux triptans dans la migraine
10. Brainstem activation in spontaneous human migraine attacks